Back to Journals » Patient Preference and Adherence » Volume 13

Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections

Total article views   HTML views PDF downloads Totals
5,838 Dovepress* 5,489+ 1,002 6,491
PubMed Central* 349 126 475
Totals 5,838 1,128 6,966
*Since 4 November 2019

View citations on PubMed Central and Google Scholar